Track topics on Twitter Track topics that are important to you
The post Reata regains rights to bardoxolone from AbbVie for $330m appeared first on Pharmaceutical Technology.
Original Article: Reata regains rights to bardoxolone from AbbVie for $330mNEXT ARTICLE
BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...